Key Finding
Acupuncture administered on the day of embryo transfer showed no statistically significant improvement in ongoing pregnancy rates or live birth rates compared to placebo acupuncture in women undergoing IVF or ICSI.
Researchers in this study wanted to find out if acupuncture performed on the day of embryo transfer could improve pregnancy success rates for women undergoing fertility treatments like IVF (in vitro fertilization) or ICSI (intracytoplasmic sperm injection). The study included 635 women who were randomly assigned to receive either real acupuncture based on traditional Chinese medicine principles or placebo acupuncture using special fake needles that don't actually pierce the skin. Neither the patients nor the researchers knew who received which treatment until after the study ended, making this a high-quality, double-blind trial.
The results showed no significant difference between the two groups. In the real acupuncture group, 27% of women achieved an ongoing pregnancy and 25% had a live birth. In the placebo group, the rates were actually slightly higher at 32% for ongoing pregnancy and 30% for live birth, though this difference wasn't statistically meaningful. These findings suggest that acupuncture performed specifically on the day of embryo transfer does not improve IVF or ICSI outcomes.
What this means for patients: If you're considering acupuncture as part of your fertility treatment, this particular approach—receiving acupuncture only on embryo transfer day—does not appear to boost your chances of pregnancy or live birth. However, this study looked at only one specific acupuncture protocol. Other research has explored different approaches, such as longer-term acupuncture treatment before and during fertility procedures. If you're interested in exploring acupuncture for fertility support, consult with a licensed acupuncturist who specializes in reproductive health.
This prospective, double-blind randomized controlled trial evaluated acupuncture's efficacy when administered on embryo transfer day in 635 patients undergoing IVF or ICSI. The treatment group (n=314) received traditional Chinese medicine-based acupuncture, while controls (n=321) received validated placebo acupuncture using non-penetrating needles. Primary outcomes showed no statistically significant differences between groups. Ongoing pregnancy rates were 27% (95% CI 22-32) in the acupuncture group versus 32% (95% CI 27-37) in placebo. Live birth rates were 25% (95% CI 20-30) versus 30% (95% CI 25-35), respectively. The placebo group demonstrated numerically higher rates, though not significantly so. Clinical takeaway: Single-session acupuncture administered at embryo transfer does not improve assisted reproductive technology outcomes. Practitioners should counsel patients that this specific protocol lacks evidence of efficacy, though other acupuncture approaches with different timing and frequency have not been evaluated by this study.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Three distinct BNC1 gene variants contribute to premature ovarian insufficiency through different molecular mechanisms, with each variant affecting separate biological pathways including immune regulation, antiviral responses, and reproductive development.
📌 LbGP supplementation significantly improved oocyte quality in aged mice by restoring mitochondrial function through PPAR signaling activation and remodeling the ovarian microenvironment by reducing inflammation and increasing functional granulosa cells.
📌 Copper deficiency during pregnancy causes fetal growth restriction by disrupting placental structure, impairing trophoblast cell function, and dysregulating lipid metabolism in the placenta.